Evaluation of clinical and genetic characteristics of cystic fibrosis patients in the Southeastern Anatolia of Turkey
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 16.09.2025. Verfasst von Elif Arik und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergy and Immunology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Mutation. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Due to the amazing developments in modulatory treatments, genetic analysis of cystic fibrosis (CF) patients has become even more important. More than 2000 disease‐causing variants of the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene have been found, and their ethnic and geographical distributions vary. We aimed to present the first genetic data from the Southeastern Anatolia region of Turkey and evaluate patients' clinical and genetic characteristics and identify modulatory drugs covering a wider range of mutations by detecting and reporting new mutations.
Methods
Our study included 337 CF patients from three CF reference centers in the Southeastern Anatolia region.
Results
Ninety‐one distinct mutations and four significant deletions were identified by analyzing CFTR mutations. The most prevalent mutation in our research was F508del (8.92%); the second most prevalent mutation was 2183AA–>G, and the third most prevalent mutation was R347P. Additionally, a novel mutation (V1160X) was identified in two siblings. Only 33.5% of our patients qualified for CFTR modulator medication therapy.
Conclusion
This study elucidates the diverse nature of CFTR mutations in the Turkish population. The heterogenous genetic pool of the Southeastern Anatolia region is more similar to Mesopotamia than to other regions of our country, and receives immigration from the East. Detection and reporting of novel mutations and CFTR mutations that occur at very low frequencies from different populations living in various geographical areas are essential for identifying modulatory medicines that cover a broader range of mutations and also help genetic diagnosis of CF in newborn screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Allergy and Immunology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
- Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
- Department of Pediatric Pulmonology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
- Department of Pediatric Pulmonology, Gaziantep Cengiz Gokcek Maternity and Children's Hospital, Gaziantep, Turkey.
- Department of Pulmonology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
- Department of Pediatrics, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
ORCID-Profile: Elif Arik, Melih Hangül
Zitieren
APA
Arik, E., Keskin, O., Korkmaz, M., Şen, V., Hangül, M., Cesur, M., Kucukosmanoglu, E., Balcı, S. O., Şen, H. S., Savaş, S., & Doğan, İ. (2025). Evaluation of clinical and genetic characteristics of cystic fibrosis patients in the Southeastern Anatolia of Turkey. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70197
Vancouver
Arik E, Keskin O, Korkmaz M, Şen V, Hangül M, Cesur M, et al. Evaluation of clinical and genetic characteristics of cystic fibrosis patients in the Southeastern Anatolia of Turkey. Pediatrics International. 2025;67(1). doi:10.1111/ped.70197
BibTeX
@article{Arik2025,
author = {Arik, Elif and Keskin, Ozlem and Korkmaz, Murat and Şen, Velat and Hangül, Melih and Cesur, Mahmut and Kucukosmanoglu, Ercan and Balcı, Sibel Oğuzkan and Şen, Hadice Selimoğlu and Savaş, Suat and Doğan, İlkay},
title = {Evaluation of clinical and genetic characteristics of cystic fibrosis patients in the Southeastern Anatolia of Turkey},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70197}
}
EUVIMED